Neurodegeneration and Neuroinflammation in cdk5/p25-Inducible Mice
- 1 February 2008
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 172 (2) , 470-485
- https://doi.org/10.2353/ajpath.2008.070693
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's diseaseAnnals of Neurology, 2007
- Neuronal loss in primary long-term cortical culture involves neurodegeneration-like cell death via calpain and p35 processing, but not developmental apoptosis or agingExperimental & Molecular Medicine, 2007
- Transgenic mouse models for Alzheimer's disease: the role of GSK-3β in combined amyloid and tau-pathologyRevue Neurologique, 2006
- Opposing Roles of Transient and Prolonged Expression of p25 in Synaptic Plasticity and Hippocampus-Dependent MemoryNeuron, 2005
- Identification and Isolation of a Hyperphosphorylated, Conformationally Changed Intermediate of Human Protein Tau Expressed in YeastBiochemistry, 2005
- p25/Cdk5-mediated retinoblastoma phosphorylation is an early event in neuronal cell deathJournal of Cell Science, 2005
- Reelin and brain developmentNature Reviews Neuroscience, 2003
- Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25‐transgenic miceJournal of Comparative Neurology, 2002
- Coexpression of Human cdk5 and Its Activator p35 with Human Protein Tau in Neurons in Brain of Triple Transgenic MiceNeurobiology of Disease, 2001
- Control of Memory Formation Through Regulated Expression of a CaMKII TransgeneScience, 1996